Skip to content
10-K

Annual Report

Revolution Medicines, Inc. RVMD RVMDW

0001193125-26-071563

← back to feed
Filed
Feb 25, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 198.17M sh
Shares Diluted FY 2025 · Dec 31, 2025 190.13M sh
Shares Diluted FY 2025 · Dec 31, 2024 167.74M sh
Shares Diluted FY 2025 · Dec 31, 2023 113.15M sh
Capex FY 2025 · Dec 31, 2025 $15.99M
Capex FY 2025 · Dec 31, 2024 $10.31M
Capex FY 2025 · Dec 31, 2023 $7.73M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$897.74M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$557.44M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$350.57M
Cash And Equivalents FY 2025 · Dec 31, 2025 $383.75M
Cash And Equivalents FY 2025 · Dec 31, 2024 $543.06M
Cash And Equivalents FY 2025 · Dec 31, 2023 $696.15M
Stockholders Equity FY 2025 · Dec 31, 2025 $1.63B
Stockholders Equity FY 2025 · Dec 31, 2024 $2.27B
Stockholders Equity FY 2025 · Dec 31, 2023 $1.83B
Stockholders Equity FY 2025 · Dec 31, 2022 $685.19M
Current Liabilities FY 2025 · Dec 31, 2025 $290.42M
Current Liabilities FY 2025 · Dec 31, 2024 $163.91M
Total Liabilities FY 2025 · Dec 31, 2025 $723.21M
Total Liabilities FY 2025 · Dec 31, 2024 $293.1M
Current Assets FY 2025 · Dec 31, 2025 $2.08B
Current Assets FY 2025 · Dec 31, 2024 $2.33B
Total Assets FY 2025 · Dec 31, 2025 $2.35B
Total Assets FY 2025 · Dec 31, 2024 $2.56B
Eps Diluted FY 2025 · Dec 31, 2025 −$5.95
Eps Diluted FY 2025 · Dec 31, 2024 −$3.58
Eps Diluted FY 2025 · Dec 31, 2023 −$3.86
Eps Basic FY 2025 · Dec 31, 2025 −$5.95
Eps Basic FY 2025 · Dec 31, 2024 −$3.58
Eps Basic FY 2025 · Dec 31, 2023 −$3.86
Sga Expense FY 2025 · Dec 31, 2025 $195.04M
Sga Expense FY 2025 · Dec 31, 2024 $97.3M
Sga Expense FY 2025 · Dec 31, 2023 $75.62M
Rd Expense FY 2025 · Dec 31, 2025 $987.33M
Rd Expense FY 2025 · Dec 31, 2024 $592.23M
Rd Expense FY 2025 · Dec 31, 2023 $423.14M
Net Income FY 2025 · Dec 31, 2025 −$1.13B
Net Income FY 2025 · Dec 31, 2024 −$600.09M
Net Income FY 2025 · Dec 31, 2023 −$436.37M
Operating Income FY 2025 · Dec 31, 2025 −$1.18B
Operating Income FY 2025 · Dec 31, 2024 −$689.52M
Operating Income FY 2025 · Dec 31, 2023 −$487.19M
Revenue FY 2025 · Dec 31, 2025 $0
Revenue FY 2025 · Dec 31, 2024 $0
Revenue FY 2025 · Dec 31, 2023 $11.58M